Antares Pharma Inc. (ATRS)
NASDAQ: ATRS
· Real-Time Price · USD
5.59
0.01 (0.18%)
At close: Apr 24, 2025, 3:47 PM
Antares Pharma Revenue
Antares Pharma reported an annual revenue of $183.98M, reflecting a 22.98% growth. For the quarter ending March 31, 2022, Antares Pharma generated $41.56M in revenue.
Revenue (ttm)
183.98M
Revenue Growth
22.98%
Price / Sales Ratio
3.3
Revenue / Employee
915.33K
Employees
201
Market Cap
0
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2021 | 183.98M | +22.98% |
Dec 31, 2020 | 149.6M | +20.78% |
Dec 31, 2019 | 123.86M | +94.90% |
Dec 31, 2018 | 63.55M | +16.58% |
Dec 31, 2017 | 54.52M | +4.39% |
Dec 31, 2016 | 52.22M | +14.38% |
Dec 31, 2015 | 45.66M | +72.28% |
Dec 31, 2014 | 26.5M | +28.53% |
Dec 31, 2013 | 20.62M | -8.67% |
Dec 31, 2012 | 22.58M | +37.17% |
Dec 31, 2011 | 16.46M | +28.39% |
Dec 31, 2010 | 12.82M | +54.24% |
Dec 31, 2009 | 8.31M | +46.82% |
Dec 31, 2008 | 5.66M | -27.95% |
Dec 31, 2007 | 7.86M | +84.07% |
Dec 31, 2006 | 4.27M | +91.86% |
Dec 31, 2005 | 2.22M | -18.98% |
Dec 31, 2004 | 2.75M | -27.49% |
Dec 31, 2003 | 3.79M | -5.23% |
Dec 31, 2002 | 4M | +14.21% |
Dec 31, 2001 | 3.5M | +75.52% |
Dec 31, 2000 | 1.99M | -42.75% |
Dec 31, 1999 | 3.48M | +26.57% |
Dec 31, 1998 | 2.75M | -25.99% |
Dec 31, 1997 | 3.72M | +0.68% |
Dec 31, 1996 | 3.69M | n/a |